Area: Strategy
How Established Firms Get Disrupted by Allies
Suppliers, distributers, product extenders go from helper to competitor
How Diversified Companies Can Redeploy Workers to Enable Growth
Experienced hands help new business lines find their way
How Antitrust Thinking on Hospital Mergers Has Been Forced to Evolve
Matt Schmitt’s research shows hospital prices rise after acquisitions, even where local competition is unchanged
Household Energy Efficiency: Not All Upgrades Are Created Equal
Behavior, other factors influence which improvements are effective
Has the Term ‘Competitive Advantage’ Outlived Its Usefulness?
Popular in business schools and executive suites, it’s no longer a meaningful way to compare companies
Gaining Status in an Online Community
How unknown individuals turn into influencers on a platform for programmers
FDA’s Breakthrough Program: Faster Drug OKs Without Sacrificing Safety
Dedicated FDA staff guide companies during design of clinical trials
Face-to-Face Meetings, Before an Acquisition, Improve Outcomes for Buyers
Acquiring companies appear to get a better deal following frequent in-person meetings
Exploring the Relationship between Off-Label Prescriptions and Clinical Trials
A study looks at how changes in FDA labeling affect pediatric utilization of drugs
Exploiting Regulatory Loophole Speeds Cancer Drug Development
Pharma companies seek OK for limited use, then expand sales through off-label prescribing, saving millions
Entrepreneurship, Riskier in Wealthy Nations, Is Actually Safer in India
Steady employment is rare — a condition some U.S. workers also endure
Do Hospital Mergers Really Cut Health Care Costs?
Matt Schmitt finds that size and location help determine how much, if any, costs fall after deals
Do Corporate Wellness Programs Boost Worker Productivity?
Industrial laundry gains 4% output; better health and better feelings toward employer could account for increase
Diversity, Economic Growth and a Bug in the Research
Whether research shows benefits from diversity depends heavily on choice of study design
Consumer Backlash to CEO Advocacy: Signaling or Act of Conscience?
An experiment seeks to isolate motivation and raises concerns for outspoken corporate leaders
CEOs Risk Alienating Customers with High-Profile Activism
Taking a stand on controversial issues can hurt sales, but the effect is brief